MAM
NBCU sells $1 bn worth ad inventory for Olympics
MUMBAI: NBCUniversal has said it has sold $1 billion worth of national television and digital advertising for the London Olympics $150 million more than what it made in the previous edition.
The ad total includes sales from across NBCU portfolio, including NBC itself, MSNBC, CNBC, Bravo, Telemundo, the NBC Sports Network, NBCOlympics.com, mobile apps and a new 3D channel.
NBCU said its decision to live stream every athletic competition on NBCOlympics.com and, for the first time, on the NBC Olympics Live Extra app for both mobile devices and tablets, significantly contributed to NBCU’s ability to reach $1 billion.
It will stream more than 3,500 hours of content including all 32 sports and 302 medals.
Digital ad sales for London have exceeded $60 million, roughly three times more than the total for Beijing when NBCOlympics.com alone live streamed 2,200 hours and 25 sports. National television ad sales for London games account for more than $950 million, up approximately $100 million from Beijing.
NBCUniversal is presenting 5,535 total hours of coverage of the 2012 London Olympics across NBC, NBC Sports Network, MSNBC, CNBC, Bravo, Telemundo, NBCOlympics.com, the NBC Olympics Live Extra mobile and tablet app, two specialty channels, and the first-ever 3D platform, an unprecedented level that surpasses the coverage of the 2008 Beijing Olympics by nearly 2,000 hours.
“This feat is a testimony to the quality of Olympic programming and the unparalleled way NBCU presents, produces and covers the Games,” NBC Sports Group EVP, Sales & Sales Marketing Seth Winter said in a statement. “It also demonstrates the power of the Olympics. No other property has such as diverse group of sponsors, who can target the broadest range of demographic and psychographic audiences. We are not done yet and will continue to sell during the Games.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
